Companies primarily engaged in the research, development, manufacturing and/or marketing of products based on genetic analysis and genetic engineering. Includes companies specializing in protein-based therapeutics to treat human diseases. Excludes companies manufacturing products using biotechnology but without a health care application.
The Biotechnology industry has on average risen 84.8% over the last 3 months. The average price/earnings ratio is 48.1 and the average return on equity is 39.8%. These averages are based on an equal weighting of the 14 most liquid stocks in this industry.
Symbol | Company Name | Setup | TA | FA | CRS | % Chg | 1 Month | 3 Month | 6 Month | PE | Market Cap | Vol(50) | Action |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 4AB.DE | ABBVIE INC | 82.21 | -1.23% | 11.05% | 24.84% | 13.84% | 22.26 | 355.08B | 493.12 | ||||
| 1AMGN.MI | AMGEN INC | 0 | -1.07% | -7.98% | 10.35% | N/A | 13.65 | 136.64B | N/A | ||||
| AMG.DE | AMGEN INC | 15.05 | -0.2% | 5.3% | 0.6% | -7.92% | 13.64 | 136.47B | 740.04 | ||||
| GIS.DE | GILEAD SCIENCES INC | 72.36 | 1.49% | -2.93% | 0.74% | -6.19% | 14.42 | 118.05B | 465.8 | ||||
| VX1.DE | VERTEX PHARMACEUTICALS INC | 8.47 | 1.03% | 1.98% | -12.16% | -21.37% | 24.18 | 89.54B | 266.06 | ||||
| ARGX.BR | ARGENX SE | 91.77 | 0.03% | 6.03% | 45.24% | 30.36% | 92.2 | 41.53B | 125.26K | ||||
| 22UA.DE | BIONTECH SE-ADR | 9.5 | 0.28% | -7.97% | -6.04% | 11.12% | N/A | 21.56B | 45.34K | ||||
| IDP.DE | BIOGEN INC | 32.04 | 2.73% | 11.4% | 20.36% | 18.68% | 9.92 | 19.84B | 391.24 | ||||
| 0QF.DE | MODERNA INC | 2.82 | 1.24% | 12.21% | -8.53% | 5.36% | N/A | 9.38B | 26.18K | ||||
| 1MRNA.MI | MODERNA INC | 2.23 | -3.01% | 5.04% | -9.46% | -27% | N/A | 9.08B | 8.62K | ||||
| ABVX.PA | ABIVAX SA | 99.65 | 3.88% | -5.62% | 927.03% | 1344% | N/A | 5.81B | 88.94K | ||||
| 2X1.DE | ABIVAX SA | 0 | 1.99% | N/A | N/A | N/A | N/A | 5.57B | N/A | ||||
| 22Z.DE | ZEALAND PHARMA A/S | 0 | 1.91% | N/A | N/A | N/A | 5.36 | 3.15B | N/A | ||||
| 1VKTX.MI | VIKING THERAPEUTICS INC | 0 | 7.58% | N/A | N/A | N/A | N/A | 2.63B | N/A | ||||
| GLPG.AS | GALAPAGOS NV | 86.41 | -0.13% | 11.96% | 30.17% | 46.32% | N/A | 2.10B | 99.98K | ||||
| 1SRPT.MI | SAREPTA THERAPEUTICS INC | 0 | 24.03% | N/A | N/A | N/A | N/A | 2.00B | N/A | ||||
| AZT.OL | ARCTICZYMES TECHNOLOGIES ASA | 94.54 | -0.37% | -0.37% | 59.41% | 73.94% | 900 | 1.38B | 46.70K | ||||
| TRMED.OL | THOR MEDICAL ASA | 98.21 | -0.13% | 4.17% | 49.4% | 70.84% | N/A | 1.32B | 3.76M | ||||
| 5CV.DE | CUREVAC NV | 89.66 | -0.04% | 0.22% | 0.61% | 93.46% | 5.3 | 1.04B | 59.26K | ||||
| NANO.PA | NANOBIOTIX | 99.53 | -1.76% | 136.11% | 296.73% | 475.1% | N/A | 805.19M | 393.02K |